BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 9314560)

  • 1. Role of interleukin 12 and costimulators in T cell anergy in vivo.
    Van Parijs L; Perez VL; Biuckians A; Maki RG; London CA; Abbas AK
    J Exp Med; 1997 Oct; 186(7):1119-28. PubMed ID: 9314560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of CTLA-4 in induction and maintenance of peripheral T cell tolerance.
    Eagar TN; Karandikar NJ; Bluestone JA; Miller SD
    Eur J Immunol; 2002 Apr; 32(4):972-81. PubMed ID: 11920563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of peripheral T cell tolerance in vivo requires CTLA-4 engagement.
    Perez VL; Van Parijs L; Biuckians A; Zheng XX; Strom TB; Abbas AK
    Immunity; 1997 Apr; 6(4):411-7. PubMed ID: 9133420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CTLA-4 regulates induction of anergy in vivo.
    Greenwald RJ; Boussiotis VA; Lorsbach RB; Abbas AK; Sharpe AH
    Immunity; 2001 Feb; 14(2):145-55. PubMed ID: 11239447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anergy in peripheral memory CD4(+) T cells induced by low avidity engagement of T cell receptor.
    Mirshahidi S; Huang CT; Sadegh-Nasseri S
    J Exp Med; 2001 Sep; 194(6):719-31. PubMed ID: 11560989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of T cell anergy in the absence of CTLA-4/B7 interaction.
    Frauwirth KA; Alegre ML; Thompson CB
    J Immunol; 2000 Mar; 164(6):2987-93. PubMed ID: 10706686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of in vivo administration of anti-CTLA-4 monoclonal antibody and IL-12 on the induction of low-dose oral tolerance.
    Barone KS; Herms B; Karlosky L; Murray S; Qualls J
    Clin Exp Immunol; 2002 Nov; 130(2):196-203. PubMed ID: 12390306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CTLA-4 blockade reverses CD8+ T cell tolerance to tumor by a CD4+ T cell- and IL-2-dependent mechanism.
    Shrikant P; Khoruts A; Mescher MF
    Immunity; 1999 Oct; 11(4):483-93. PubMed ID: 10549630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Control of CD4 T cell fate by antigen re-stimulation with or without CTLA-4 engagement 24 h after priming.
    Nakata Y; Uzawa A; Suzuki G
    Int Immunol; 2000 Apr; 12(4):459-66. PubMed ID: 10744647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of CD25(+)CD4(+) regulatory T cells by oral antigen administration.
    Zhang X; Izikson L; Liu L; Weiner HL
    J Immunol; 2001 Oct; 167(8):4245-53. PubMed ID: 11591746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Signaling through CD28 and CTLA-4 controls two distinct forms of T cell anergy.
    Wells AD; Walsh MC; Bluestone JA; Turka LA
    J Clin Invest; 2001 Sep; 108(6):895-903. PubMed ID: 11560959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B7 and interleukin 12 cooperate for proliferation and interferon gamma production by mouse T helper clones that are unresponsive to B7 costimulation.
    Murphy EE; Terres G; Macatonia SE; Hsieh CS; Mattson J; Lanier L; Wysocka M; Trinchieri G; Murphy K; O'Garra A
    J Exp Med; 1994 Jul; 180(1):223-31. PubMed ID: 7516409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CTLA-4 is not required for induction of CD8(+) T cell anergy in vivo.
    Frauwirth KA; Alegre ML; Thompson CB
    J Immunol; 2001 Nov; 167(9):4936-41. PubMed ID: 11673499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CTLA-4 regulates expansion and differentiation of Th1 cells following induction of peripheral T cell tolerance.
    Eagar TN; Turley DM; Padilla J; Karandikar NJ; Tan L; Bluestone JA; Miller SD
    J Immunol; 2004 Jun; 172(12):7442-50. PubMed ID: 15187122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T cells of staphylococcal enterotoxin B-tolerized autoimmune MRL-lpr/lpr mice require co-stimulation through the B7-CD28/CTLA-4 pathway for activation and can be reanergized in vivo by stimulation of the T cell receptor in the absence of this co-stimulatory signal.
    Zhou T; Weaver C; Linsley PS; Mountz JD
    Eur J Immunol; 1994 May; 24(5):1019-25. PubMed ID: 7514125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of CTLA-4 in tolerance induction and ttigen administration cell differentiation in experimental autoimmune encephalomyelitis: i. v. antigen administration.
    Ratts RB; Arredondo LR; Bittner P; Perrin PJ; Lovett-Racke AE; Racke MK
    Int Immunol; 1999 Dec; 11(12):1889-96. PubMed ID: 10590254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human gamma delta T cells are resistant to induction of anergy but not to induction of cell death in vitro.
    Pawelec G; Friccius H; Boshell M; Siegels-Hübenthal P; Rehbein A; Schlotz E; Pohla H; Schaudt K; Sansom D
    Cell Immunol; 1995 Apr; 162(1):8-15. PubMed ID: 7704914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roles of cytotoxic T-lymphocyte-associated antigen-4 in the inductive phase of oral tolerance.
    Chen Y; Ma Y; Chen Y
    Immunology; 2002 Feb; 105(2):171-80. PubMed ID: 11872092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD152 ligation by CD80 on T cells is required for the induction of unresponsiveness by costimulation-deficient antigen presentation.
    Chai JG; Vendetti S; Amofah E; Dyson J; Lechler R
    J Immunol; 2000 Sep; 165(6):3037-42. PubMed ID: 10975813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo tolerization of Th1 lymphocytes following a single feeding with ovalbumin: anergy in the absence of suppression.
    Melamed D; Friedman A
    Eur J Immunol; 1994 Sep; 24(9):1974-81. PubMed ID: 8088317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.